Immupharma PLC Holding(s) in Company (8539D)
February 05 2018 - 2:00AM
UK Regulatory
TIDMIMM
RNS Number : 8539D
Immupharma PLC
05 February 2018
5 February 2018
ImmuPharma PLC
("ImmuPharma" or the "Company")
Notification of Major Interest
Lanstead Increases Holding to over 5%
ImmuPharma PLC (LSE:IMM), the specialist drug discovery and
development company, has received notification that Lanstead
Capital LP ("Lanstead") has confirmed an increase in its holding in
ImmuPharma. Lanstead now holds 6,985,893 Ordinary shares of 10p
each in the Company, representing 5.01% of ImmuPharma's issued
share capital of 139,467,430 Ordinary shares with voting
rights.
This announcement contains inside information for the purposes
of Article 7 of Regulation (EU) 596/2014.
For further information, please contact:
ImmuPharma plc (www.immupharma.com) + 44 (0) 207 152
Tim McCarthy, Chairman 4080
Lisa Baderoon, Head of Investor
Relations +44 (0) 7721 413
lisa.baderoon@immupharma.com 496
-------------------------------------- -----------------------
Northland Capital Partners Limited
David Hignell, Jamie Sportswood
(Corporate Finance)
Rob Rees (Corporate Broking) +44 (0) 203 861 6625
-------------------------------------- -----------------------
TR-1: Standard form for notification of major holdings
follows:
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant
issuer and to the FCA in Microsoft Word format if possible)(i)
----------------------------------------------------------------------------------------------------
1a. Identity of the issuer Immupharma plc
or the underlying issuer
of existing shares to which
voting rights are attached(ii)
:
------------------------------------------------- -------------------------------------------------
1b. Please indicate if the issuer is a non-UK issuer
(please mark with an "X" if appropriate)
----------------------------------------------------------------------------------------------------
Non-UK issuer
------------------------------------------------------------------------------------- -------------
2. Reason for the notification (please mark the appropriate
box or boxes with an "X")
----------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights X
------------------------------------------------------------------------------------- -------------
An acquisition or disposal of financial instruments
------------------------------------------------------------------------------------- -------------
An event changing the breakdown of voting rights
------------------------------------------------------------------------------------- -------------
Other (please specify)(iii) :
------------------------------------------------------------------------------------- -------------
3. Details of person subject to the notification obligation(iv)
Name Lanstead Capital LP
City and country of registered
office (if applicable)
4. Full name of shareholder(s) (if different from 3.)(v)
----------------------------------------------------------------------------------------------------
Name
------------------------------------------------- -------------------------------------------------
City and country of registered
office (if applicable)
------------------------------------------------- -------------------------------------------------
5. Date on which the threshold 02/02/2018
was crossed or reached(vi)
:
------------------------------------------------- -------------------------------------------------
6. Date on which issuer notified 02/02/2018
(DD/MM/YYYY):
------------------------------------------------- -------------------------------------------------
7. Total positions of person(s) subject to the notification
obligation
----------------------------------------------------------------------------------------------------
% of voting % of voting Total of Total number
rights attached rights through both in % of voting
to shares financial (8.A + 8.B) rights of
(total of instruments issuer(vii)
8. A) (total of
8.B 1 + 8.B
2)
---------------------- ------------------------- ---------------- ---------------- -------------
Resulting
situation
on the date
on which
threshold
was crossed
or reached 5.01% 0.00% 5.01% 139,467,430
---------------------- ------------------------- ---------------- ---------------- -------------
Position
of previous
notification
(if
applicable) 4.90% 0.00% 4.90%
---------------------- ------------------------- ---------------- ---------------- -------------
8. Notified details of the resulting situation on the
date on which the threshold was crossed or reached(viii)
--------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares
--------------------------------------------------------------------------------------------------------------
Class/type Number of voting rights(ix) % of voting rights
of
shares
ISIN code
(if possible)
-----------------------
Direct Indirect Direct Indirect
(Art 9 of (Art 10 of (Art 9 of (Art 10 of
Directive Directive Directive Directive
2004/109/EC) 2004/109/EC) 2004/109/EC) 2004/109/EC)
(DTR5.1) (DTR5.2.1) (DTR5.1) (DTR5.2.1)
---------------------- --------------------- -------------- ------------------------------ --------------
Ordinary
Shares
ISIN: GB0033711010 6,985,893 0 5.01% 0.00%
----------------------- --------------------- -------------- ------------------------------ --------------
SUBTOTAL
8. A 6,985,893 5.01%
----------------------- ------------------------------------- ----------------------------------------------
B 1: Financial Instruments according to Art. 13(1)(a)
of Directive 2004/109/EC (DTR5.3.1.1 (a))
--------------------------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date(x) Conversion rights that rights
Period(xi) may be acquired
if the instrument
is
exercised/converted.
----------------------- --------------------- -------------- ------------------------------ --------------
N/A
----------------------- --------------------- -------------- ------------------------------ --------------
SUBTOTAL 8.
B 1
-------------- ------------------------------ --------------
B 2: Financial Instruments with similar economic effect
according to Art. 13(1)(b) of Directive 2004/109/EC
(DTR5.3.1.1 (b))
--------------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Physical Number % of voting
financial date(x) Conversion or cash of voting rights
instrument Period settlement(xii) rights
(xi)
---------------------- ---------------------- -------------- ----------------- ----------- --------------
N/A
----------------------- --------------------- -------------- ----------------- ----------- --------------
SUBTOTAL
8.B.2
----------------- ----------- --------------
9. Information in relation to the person subject to
the notification obligation (please mark the
applicable box with an "X")
Person subject to the notification obligation is
not controlled by any natural person or legal entity
and does not control any other undertaking(s) holding
directly or indirectly an interest in the (underlying)
issuer(xiii)
Full chain of controlled undertakings through which
the voting rights and/or the
financial instruments are effectively held starting
with the ultimate controlling natural person or
legal entity(xiv) (please add additional rows as
necessary)
-------------------------------------------------------------- ---------------------
Name(xv) % of voting % of voting Total of both
rights if it rights through if it equals
equals or is financial instruments or is higher
higher than if it equals than the notifiable
the notifiable or is higher threshold
threshold than the notifiable
threshold
------------- ------------------ ------------------------- -----------------------
N/A
------------- ------------------ ------------------------- -----------------------
10. In case of proxy voting, please identify:
-------------------------------------------------------------------------------------
Name of the proxy holder
--------------------------------- --------------------------------------------------
The number and % of voting
rights held
--------------------------------- --------------------------------------------------
The date until which the
voting rights will be held
--------------------------------- --------------------------------------------------
11. Additional information(xvi)
-------------------------------------------------------------------------------------
Place of completion
-------------------- -----------
Date of completion 02/02/2018
-------------------- -----------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLKZLFBVLFEBBE
(END) Dow Jones Newswires
February 05, 2018 02:00 ET (07:00 GMT)
Immupharma (LSE:IMM)
Historical Stock Chart
From Mar 2024 to Apr 2024
Immupharma (LSE:IMM)
Historical Stock Chart
From Apr 2023 to Apr 2024